Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Rabin Medical Center
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
All patients must satisfy current diagnostic criteria for pulmonary artery hypertension based on their historical right heart catheter data (within 4 years of study enrollment): Mean PAP \>25mmHg at rest or \>30mmHg with exercise, by a PCWP \<= 15mmHg and by PVR \>3 Wood Units.
Willing and able to participate in 24 bi-weekly rehabilitation sessions, and medical follow-up.
Stable dose of current PAH-specific medication for 3 months prior to enrollment.
New York Heart Association (NYHA) Class II-III.
Women of child-bearing age must demonstrate adequate contraception or undergo a pregnancy test.
You may not be if
Functional Class NYHA Class I or IV.
PAH due to congenital heart disease, left heart disease, chronic lung diseases (VC or FEV1 \< 60% of predicted) or chronic hypoxia.
Acute intercurrent illness requiring hospital admission in the month proceeding screening.
Any non-PAH medical condition likely to interfere with participation in rehabilitation, e.g. musculoskeletal disorders.
Any uncontrolled or terminal non-PAH medical condition likely to interfere with completion of the study, according to the judgment of the study physician.
Participation in another rehabilitation scheme within 6 months of enrollment in the study.
Current participation in another clinical trial.
Pregnancy or planned pregnancy during the study period.
Clareo Health | Rehabilitation for Patients With Pulmonary Arterial Hypertension
